Abstract: A hose (10) comprising a tubular body (12) of flexible material arranged between an inner and an outer helically wound wire (22, 24). The hose (10) further comprises an axial strengthening means (20) adapted to reduce deformation of the tubular body (12) when the tubular body (12) is subjected to axial tension, the axial strengthening means (20) being adapted to exert a radially inward force on at least part of the tubular body (12) when axial strengthening means (20) is subjected to axial tension.

Abstract: The present invention provides histone deacetylase inhibitors of general formula (I), a process for the preparation of such compounds and uses of the compounds in medicine, especially in the treatment of cancers: in which R1 is an optionally substituted aryl, arylalkyl, heteroaryl, heterocycloalkenyl, cycloalkene ring, cycloalkyl, heterocycloalkyl or a combination of such rings to form a linked or fused ring system, R2 and R3 is each independently hydrogen, optionally substituted saturated or unsaturated alkyl, optionally substituted aryl or heteroaryl, or a combination thereof to form a linked or fused ring system, alkoxy, thioalkoxy, hydroxyl, hydroxyalkyl, halo, haloalkyl, cyano, nitro, amino, amido, alkylamino, alkylcarbonyloxy, alkoxycarbonyl, alkylcarbonyl, alkylthiocarbonyl, alkylsulfonylamino, aminosulfonyl, alkylsulfinyl, or alkylsulfonyl, or R3 is absent when Y stands for O or S, or R2 and R3 may be linked together and such that, together with the intervening atoms, they form a 5, 6 or 7-membered ri

Abstract: A hose (10) comprising a tubular body (12) of flexible material arranged between an inner and an outer helically wound wire (22, 24). The hose (10) further comprises an elongate member having opposing longitudinal edges, the elongate member being helically wound around the tubular body such that the opposing longitudinal edges of the layer are in an adjacent or overlapping arrangement, wherein each longitudinal edge includes a formation capable of interengaging with a cooperating formation on the opposing longitudinal edge.

Abstract: This invention relates to a new and distinctive short-day cultivar, designated as ‘Viva Patricia’, primarily adapted to the growing conditions in Spain. This short-day (Mediterranean) cultivar is primarily characterized by an upright and dense growth habit, a large fruit size having superior uniformity, a primarily conical shaped berry exhibiting a glossy bright red appearance, a significantly better flavored and aromatic berry providing a more pleasant eating experience, a firmer fruit skin, an increased number of flowers and fruits per truss, a very moderate petiole pubescence, and an early to mid-season production with substantial yields and excellent commercial ratings.

Abstract: A method for treating bottom ash from a waste incineration plant. The invention relates in particular to a method for treating bottom ash from a domestic waste incineration plant. In accordance with the invention bottom ash having a size ranging up to 2 mm is treated by removing a previously determined component. The treatment comprises at least one of the following steps: the removal of organic components, the removal of heavy metals, the removal of ions and the removal of a fraction having a size of up to 50 ?m. It is preferred for the nonferrous heavy metals to be removed and the ferrous metals to remain in the fraction. Most preferably at least one of the treatment steps comprises a wet treatment.

Abstract: An end fitting for terminating an end of a hose including a tubular body of flexible material arranged between inner and outer gripping members, wherein the end fitting includes: an inner member adapted to be disposed at least partially within the hose; a sealing member adapted to seal at least part of the tubular body fully around the circumference between the sealing member and the inner member; and a separate load transfer member adapted to transfer axial loads between the hose and the inner member in such a manner that said axial loads are diverted around the sealing member in order to reduce, or eliminate, the axial load on the hose between the sealing member and the inner member, and wherein the sealing member is adapted to seal against the tubular body independently of the application of axial loads between the hose and the inner member.

Abstract: A homogenous process for the hydrogenation of the carboxylic acids and/or derivatives thereof in the presence of a catalyst comprising ruthenium, rhodium, iron, osmium or palladium, and an organic phosphine is described in which the hydrogenation is carried out in the presence of at least about 1% by weight water. A process for regenerating a catalyst comprising ruthenium, rhodium, iron, osmium or palladium and an organic phosphine is also described in which the regeneration is carried out in the presence of hydrogen and water.

Abstract: A homogenous process for the hydrogenation of the carboxylic acids and/or derivatives thereof in the presence of a catalyst comprising ruthenium, rhodium, iron, osmium or palladium, and an organic phosphine is described in which the hydrogenation is carried out in the presence of at least about 1% by weight water. A process for regenerating a catalyst comprising ruthenium, rhodium, iron, osmium or palladium and an organic phosphine is also described in which the regeneration is carried out in the presence of hydrogen and water.

Abstract: A method of forming a shadowgraph image is described, comprising the steps of illuminating a glazing (52), e.g., a vehicle windscreen, with light from a localized light source (50), said light being expanded and collimated by a lens optical system (54) or a mirror optical system, forming a virtual shadowgraph image of the glazing in a virtual image plane (56), which may be positioned behind or in front of the glazing: and imaging the virtual image onto a CCD camera (62). The glazing may be moving relative to the light source or may be stationary.

Abstract: Methods, apparatuses and systems directed to creating contextually-targeted advertisements. In a particular implementation, advertisers may leverage a W4 COMN to deliver contextually-targeted and/or contextually-enhanced advertisements. In the implementations discussed below, an ad creation system utilizes data made available by the W4 COMN to facilitate the creation and placement of advertisements on a message delivery network, such as the W4 COMN itself.

Abstract: There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22.

Abstract: A heavy duty excavator bucket is constructed with an exoskeletal structure comprising coupled cast components including a lip member, opposed wing members, junction members locatable between floor and side walls and side and rear walls and a cap rail structure extending between opposed wing members about the upper periphery of the bucket to form an integral structure. Steel plate floor, side wall and rear wall members extend between adjacent exoskeletal regions. The bucket may include a cast arch member extending between opposed wing members and a cast reinforcing member extending between opposed junction members adjacent said rear wall.

Abstract: A method of inspecting the fragmentation pattern of a single ply of toughened glass, following a fragmentation test carried out in accordance with ECE R43 involves illuminating a first portion of the ply of glass in transmission using a strip light source located on a first side of the transparent support. An image of the first portion of the ply of glass is captured using an image capture device located on a second side of the transparent support means, aligned with and fixed in a relative position to the strip light source. A series of images of the glass are collected and analyzed to produce an image of the fragmentation pattern. Imaging can be performed using an apparatus for carrying out the imaging.

Abstract: An object detection portal wherein a video image is obtained of a volume or area being scanned, and location of a threat object is determined and displayed in real time as an indicator overlay on the video image. An individual subject being scanned may be continuously monitored by an operator during an object divesting process, and an operator may view the threat object moving from or remaining with the subject. Object location information is supplied to a video driver to superimpose the overlay on a real time image of a subject. The scanning portal may interact with an exit barrier. The exit barrier may be activated automatically in response to sensing of a threat.

Abstract: A process for the hydrogenolysis of a sugar feedstock in the presence of a catalyst comprising: (a) ruthenium or osmium; and (b) an organic phosphine; and wherein the hydrogenolysis is carried out in the presence of water and at a temperature of greater than 150° C.

Abstract: Example systems and methods are directed at maintaining and retrieving presence metadata. One example method includes receiving a request from a first client to edit a document file, and sending short-term check out metadata to the first client to begin an editing session. The method also includes writing the transition ID to a transition table stored in a cache, wherein the presence of another transition ID in the cache indicates that a document has switched from a single-client mode to a multi-client mode. An example system includes a processing unit operative to receive a document, the document including short-term check out metadata indicating an editing session has begun, ping a cache to determine if another transition ID is stored in the cache, and send a transition ID to a transition table stored in a cache to switch from a single-client mode to a multi-client mode.

Abstract: Examples are related to systems and methods for controlling access to document files on a document server. One example system includes document files stored on a document server, at least one of the document files referencing a file lock, and a document access processing module. The example document access processing module includes a file sharing processing module that determines a coauthoring status of a software application of a client computer requesting access to the document file, and a file lock processing module that stores one or more file locks and that controls the setting and resetting of file locks. The example document access processing module uses the coauthoring status of the software application and the file lock status of a document file to determine whether a software application is permitted to have write access to the document file.

Abstract: There are disclosed antibody molecules containing at least on CDR derived from a mouse monoclonal antibody having specificity for human KDR. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases in which VEGF and/or KDR are implicated.

Abstract: An apparatus, system, and method for improving force and torque sensing and feedback to the surgeon performing a telerobotic surgery are provided. In one embodiment, a robotic surgical manipulator system, a robotic surgical system, and a method for improved sensing of forces on a robotic surgical instrument and/or manipulator arm are disclosed.

Abstract: The present invention relates to compounds of the general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5?-methylthioadenosine phosphorylases (MTAP), 5?-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.